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Resistant
Salmonella
Virchow in Quail
Products
To the Editor: Salmonella  spp.
resistant to multiple antimicrobial
agents have emerged worldwide in
recent years, but clinical relevance
varies with the agent to which resist-
ance evolves. Fluoroquinolones are
often the drug of choice to treat gas-
trointestinal infections in humans, and
resistance to this class of antimicro-
bial agents is associated with
increased illness and death (1).
Resistance to fluoroquinolones has
emerged worldwide during the last
decade.  Salmonella isolates resistant
to oxyiminocephalosporins because
they produce extended-spectrum β-
lactamases (ESBLs) have emerged
worldwide since 1992. This emer-
gence has caused concern since
cephalosporins are drugs of choice to
treat salmonellosis in children, to
whom fluoroquinolones must not be
administered because of toxicity
issues. In Denmark, the first ESBL-
producing isolate of animal origin
from a Salmonella enterica serovar
Heidelberg isolated from a boar
imported from Canada in 2003 was
reported (2), but such isolates have
not previously been reported in food
products.
On October 15, 2003, the Danish
Institute for Veterinary Research, the
national reference laboratory,
received 3 Salmonella isolates found
in quails imported from France.
Salmonella isolates found at any
importer’s laboratory in Denmark are
submitted to the reference laboratory
for further analyses. The quails were
in the importer’s storage room at the
time of sampling; sampling was per-
formed routinely by the importer’s
own laboratory. At the reference labo-
ratory, the isolates were serotyped as
S. enterica serovar Virchow and
found resistant to ampicillin, ceftio-
fur, cephalothin, nalidixic acid, and
tetracycline and with reduced suscep-
tibility to ciprofloxacin (MICs >0.125
µg/mL) (3). Polymerase chain reac-
tion detection and sequencing (4)
showed that the β-lactam resistance
was mediated by blaCTX-M-9. Pulsed-
field gel electrophoresis was per-
formed by using XbaI and BlnI as
restriction enzymes according to the
PulseNet protocol (5), and all 3 iso-
lates had the same profile.
On October 23, the importer was
informed of the laboratory’s findings
and the increased risk associated with
salmonella isolates simultaneously
resistant to quinolones and
cephalosporins. Based on this infor-
mation, the importer withdrew the
product from the supermarkets on
October 24. Recently, S.  enterica
Virchow with blaCTX-M-9 has also been
reported in poultry, poultry products,
and humans in France (6), as well as
humans in Spain (7) and the United
Kingdom (8). The isolates from
France were also resistant to nalidixic
acid; the isolates we have obtained
from fresh quails imported from
France are possibly related to these
isolates.
The global food-products trade is
expected to increase in the future.
Thus, attempts to improve food safety
must emphasize detection of antimi-
crobial drug–resistant bacteria in
imported food products. Furthermore,
international agreements that limit
contamination with drug-resistant
bacteria and resistance genes at the
primary production site are necessary
to ensure consumer safety (9).
International agreements must be
based on antimicrobial-resistance data
and early reports of emerging prob-
lems. Recently, the World Health
Organization (WHO) launched the
Global Salm Surv program (10) to
isolate and identify antimicrobial
resistance to Salmonella globally. 
Many national and international
rules, as well as marketing and con-
sumer factors, regulate the interna-LETTERS
tional trade of food products and live
animals. Large international corpora-
tions may also affect international
trade. For example, McDonald’s
Corporation has issued a global policy
for antimicrobial drug use in food ani-
mals that specifies requirements for
their food product suppliers. Local
groceries or supermarkets may also
impose their own standards national-
ly. We are aware of only 1 product
withdrawal related to antimicrobial
resistance, the quail imported from
France.
No international standards exist
for managing food safety problems
related to antimicrobial resistance.
However, in 2003 the Food and
Agriculture Organization of the
United Nations, WHO, and the World
Organisation for Animal Health joint-
ly hosted a workshop with a panel of
experts to scientifically assess resist-
ance risks related to nonhuman use of
antimicrobial drugs (9). The panel’s
purpose was also to provide recom-
mendations to the Codex
Alimentarius Commission for future
risk management of antimicrobial
drug resistance (9). Imposing restric-
tions on products with combinations
of resistance, such as simultaneous
resistance to quinolones and
cephalosporins in Salmonella, as
reported in this study, would be a
good first step towards managing
antimicrobial drug–resistance risks.
Frank M. Aarestrup,* 
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Vancomycin-
resistant
Enterococcus 
faecium Clone in
Swine, Europe 
To the Editor: The use of antimi-
crobial agents for growth promotion
(AGP) in food-producing animals has
been extensively debated because of
the risk of establishing a reservoir of
antimicrobial resistance genes or
antimicrobial-resistant organisms of
potential relevance for human health.
This concern has motivated the pro-
gressive ban of the use of different
AGP in the European Union, which
began in 1997 with avoparcin and will
end in 2006 (1). Worldwide trade of
living animals for food production or
breeding and of meat products
enables multidrug-resistant pathogens
to spread across national borders. 
Intercontinental dissemination of
antimicrobial-resistant bacteria asso-
ciated with food animals has been
described for particular clones such as
Salmonella enterica Typhimurium
DT104 or Escherichia coli O157:H7
and for transferable genetic elements
such as the genomic island SG1 or the
streptococcal plasmid pRE25 (2).
Vancomycin-resistant enterococci
(VRE) in European farms were ini-
tially associated with the intensive use
of avoparcin; however, the persist-
ence of VRE in food animal environ-
ments after years of avoparcin with-
drawal indicates that coselection by
further antimicrobial or other agents,
increased fitness of strains, and
mobile genetic elements cannot be
ruled out (1–3).
A specific clone was recently
detected among vancomycin-resistant
E. faecium (VREF) isolated from dif-
ferent swine farms in Denmark and
Switzerland and from a healthy
Danish woman without antimicrobial
drug exposure who ate pork, chicken,
and beef (4,5). Since Portugal and
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